Paid Clinical Trials Iowa City

Discover 519 paid clinical trials in Iowa City, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 519

A Study of SGN-PDL1V in Advanced Solid TumorsA Study of SGN-PDL1V in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Seagen Inc.

Location:

Iowa City IA, Farmington Hills MI, Detroit MI, Cleveland OHshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Recruiting

PHASE3

Sponsor:

Chimerix

Location:

Iowa City IA, Madison WI, Rochester MN, Chicago ILshow 53 more

Code:

NCT05580562

Conditions

H3 K27M

Glioma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Dordaviprone (ONC201)

Dordaviprone (ONC201) + Placebo

Placebo

Losartan for Improved Vascular Endothelial Function After PreeclampsiaLosartan for Improved Vascular Endothelial Function After Preeclampsia

Recruiting

EARLY_PHASE1

Sponsor:

Anna Stanhewicz, PhD

Location:

Iowa City IA

Code:

NCT04632589

Conditions

Preeclampsia Postpartum

Eligibility Criteria

Sex: Female

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

Losartan Potassium

Placebo

Specimen Collection from Pregnant Women At Increased Risk for Fetal AneuploidySpecimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Recruiting

Sponsor:

Sequenom, Inc.

Location:

Iowa City IA, Chicago IL, Grand Rapids MI, Detroit MIshow 7 more

Code:

NCT01429389

Conditions

Down Syndrome

Fetal Aneuploidy

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Iowa City IA, Cedar Rapids IA, Bettendorf IA, Moline ILshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

Recruiting

PHASE2

Sponsor:

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Location:

Iowa City IA, Chicago IL, Milwaukee WI, Saint Louis MOshow 49 more

Code:

NCT04945460

Conditions

Hypertension, Pulmonary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotatercept 0.3 mg/kg

Placebo

Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary FibrosisA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

Recruiting

PHASE3

Sponsor:

Bristol-Myers Squibb

Location:

Iowa City IA, Peoria IL, Maywood IL, Evanston ILshow 87 more

Code:

NCT06003426

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

BMS-986278

BMS-986278 Placebo

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple MyelomaStudy of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting

PHASE2

Sponsor:

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Location:

Iowa City IA, Madison WI, Rochester MN, Chicago ILshow 34 more

Code:

NCT06297226

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Arlocabtagene Autoleucel (BMS-986393)

National Collaborative to Improve Care of Children With Complex Congenital Heart DiseaseNational Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Iowa City IA, Madison WI, Oak Lawn IL, Chicago ILshow 53 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeStudy of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Recruiting

PHASE3

Sponsor:

ACADIA Pharmaceuticals Inc.

Location:

Iowa City IA, Chicago IL, Saint Louis MO, Kansas City MOshow 19 more

Code:

NCT06173531

Conditions

Hyperphagia in Prader-Willi Syndrome

Eligibility Criteria

Sex: All

Age: 5 - 30

Healthy Volunteers: Not accepted

Interventions

Carbetocin

Placebo